Login / Signup

Lacosamide in status epilepticus: Systematic review of current evidence.

Adam StrzelczykJohann Philipp ZöllnerLaurent M WillemsJulie JostEsther PauleSusanne Schubert-BastFelix RosenowSebastian Bauer
Published in: Epilepsia (2017)
The available data regarding the use of LCM in SE are promising, with a success rate of 57%. The strength of LCM is the lack of interaction potential and the option for intravenous use in emergency situations requiring rapid uptitration.
Keyphrases